ArticleJournal of neurosurgery. Case lessons2026
Cervical vertebral body metastasis from a gonadotroph pituitary neuroendocrine tumor: illustrative case.
Article in Journal of neurosurgery. Case lessons, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMetastatic dissemination of pituitary neuroendocrine tumors (PitNETs) is uncommon and portends a poor prognosis. Within this spectrum, osseous involvement of the vertebral body is particularly rare, and, specifically for the gonadotroph subtype, cervical vertebral body metastasis has not, to the authors' knowledge, been documented. OBSERVATIONS: The authors report a clinically nonfunctioning gonadotroph PitNET with histologically confirmed C5 vertebral metastasis. A 40-year-old man, who had undergone multiple surgeries for recurrent pitNET, presented with severe axial neck pain and a destructive C5 vertebral body lesion. He underwent an anterior C5 corpectomy with C4-6 reconstruction, followed by posterior lateral mass fixation for mechanical stabilization. Pathological analysis demonstrated an SF-1/follicle-stimulating hormone-positive tumor with a high Ki-67 labeling index of 10%-13%, consistent with the previous highly aggressive primary sellar lesion. Postoperative adjuvant therapy consisted of capecitabine-temozolomide and focal radiotherapy. LESSONS: This case extends the recognized spectrum of spinal dissemination in PitNETs and underscores the need for whole-axis surveillance and multimodal, multidisciplinary management in clinically aggressive PitNETs. https://thejns.org/doi/10.3171/CASE2672.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.